Cantargia AB (publ) (STO:CANTA)
Sweden · Delayed Price · Currency is SEK 5.27
-0.25 (-4.53%)
Jan 21, 2026, 12:50 PM CET
Cantargia AB Market Cap
Cantargia AB has a market cap or net worth of 1.37 billion as of January 21, 2026. Its market cap has increased by 226.63% in one year.
Market Cap
1.37B
Enterprise Value
1.03B
Revenue
308.69M
Ranking
n/a
PE Ratio
9.17
Stock Price
5.27
Market Cap Chart
Since March 17, 2015, Cantargia AB's market cap has increased from 120.55M to 1.37B, an increase of 1,038.36%. That is a compound annual growth rate of 25.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.37B | 31.90% |
| Dec 30, 2025 | 1.04B | 147.63% |
| Dec 30, 2024 | 420.15M | -38.81% |
| Dec 29, 2023 | 686.62M | 33.50% |
| Dec 30, 2022 | 514.32M | -72.19% |
| Dec 30, 2021 | 1.85B | -68.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 3.12B |
| Saniona AB | 3.02B |
| Flerie AB | 2.83B |
| BioInvent International AB | 1.87B |
| Egetis Therapeutics AB | 1.77B |
| Diamyd Medical AB | 1.70B |
| Genovis AB (publ.) | 1.37B |
| SynAct Pharma AB | 1.22B |